Health and Healthcare

Short Sellers Increase Bets in Major Biotechs

The short interest data are out for the September 30 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can make or break them. A single failed clinical trial can mean disaster for a stock. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.

The September 30 short interest data have been compared with the previous figures, and short interest increased in most of these selected stocks for this settlement date.

Amgen Inc. (NASDAQ: AMGN) saw its short interest jump to 11.01 million shares from the previous level of 10.4 million. Shares closed Friday at $149.59, in a 52-week trading range of $127.67 to $181.81.

Biogen Inc. (NASDAQ: BIIB) had its short interest rise to 5.15 million shares from the previous 4.59 million. Shares closed Friday at $269.16, within a 52-week trading range of $265.00 to $480.18.

Celgene Corp. (NASDAQ: CELG) short interest for this settlement date increased to 16.53 million shares from the previous reading of 14.95 million. Shares of Celgene closed Friday at $117.38, in a 52-week range of $83.16 to $140.72.

Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest drop to 28.39 million shares, from 29.60 million in the previous period. Shares closed Friday at $100.65, in a 52-week trading range of $85.95 to $123.37.

ALSO READ: The 6 Most Shorted Nasdaq Stocks

MannKind Corp. (NASDAQ: MNKD) saw its short interest increase very slightly to 126.84 million shares. The previous reading was 126.66 million. This is the highest reading on the year. Shares closed Friday at $3.05, in a 52-week trading range of $2.98 to $7.88.

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) short interest decreased to 6.62 million from the previous level of 6.66 million. The mid-June level was far and away the highest reading on the year, and since that time shares have backed off significantly. Shares closed Friday at $161.08, in a 52-week range of $142.02 to $208.88.

100 Million Americans Are Missing This Crucial Retirement Tool

The thought of burdening your family with a financial disaster is most Americans’ nightmare. However, recent studies show that over 100 million Americans still don’t have proper life insurance in the event they pass away.

Life insurance can bring peace of mind – ensuring your loved ones are safeguarded against unforeseen expenses and debts. With premiums often lower than expected and a variety of plans tailored to different life stages and health conditions, securing a policy is more accessible than ever.

A quick, no-obligation quote can provide valuable insight into what’s available and what might best suit your family’s needs. Life insurance is a simple step you can take today to help secure peace of mind for your loved ones tomorrow.

Click here to learn how to get a quote in just a few minutes.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.

AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.